Department of Oncology, The First Affiliated Hospital of Dalian Medical University, Dalian, China.
Department of Oncology, Affiliated Zhongshan Hospital of Dalian University, Dalian, China.
Front Immunol. 2023 Jan 19;13:1039260. doi: 10.3389/fimmu.2022.1039260. eCollection 2022.
Innate immune cells in the tumor microenvironment (TME) mainly include macrophages, neutrophils, natural killer cells, dendritic cells and bone marrow derived suppressor cells. They play an anti-tumor or pro-tumor role by secreting various cytokines, chemokines and other factors, and determine the occurrence and development of tumors. Comprehending the role of innate immune cells in tumorigenesis and progression can help improve therapeutic approaches targeting innate immune cells in the TME, increasing the likelihood of favorable prognosis. In this review, we discussed the cell biology of innate immune cells, their role in tumorigenesis and development, and the current status of innate immune cell-based immunotherapy, in order to provide an overview for future research lines and clinical trials.
肿瘤微环境(TME)中的固有免疫细胞主要包括巨噬细胞、中性粒细胞、自然杀伤细胞、树突状细胞和骨髓来源的抑制细胞。它们通过分泌各种细胞因子、趋化因子和其他因素发挥抗肿瘤或促肿瘤作用,并决定肿瘤的发生和发展。理解固有免疫细胞在肿瘤发生和进展中的作用有助于改善针对 TME 中固有免疫细胞的治疗方法,增加有利预后的可能性。在这篇综述中,我们讨论了固有免疫细胞的细胞生物学、它们在肿瘤发生和发展中的作用以及基于固有免疫细胞的免疫治疗的现状,以期为未来的研究方向和临床试验提供概述。